A clinical trial to study the effects of two drugs ,Brihat gangadhar churna and Cologrit formulation in patients with Irritable bowel syndrome

Comparative Clinical Evaluation of Brihat gangadhar churna and Cologrit formulation in Grahani roga - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058353

Enrollment

Registered

2023-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Grahani with features of Irritable bowel syndrome as per rome IV criteria Patients aged between 18-60 yrs. Patients of either gender. Patients willing to participate and giving informed consent.

Exclusion criteria

Exclusion criteria: Patients with a history of IBD , celiac disease , abdominal surgeries, ulcerative colitis. Patients suffering from any other type of systemic disorder like hypothyroidism, uncontrolled DM and HTN, cardiac disease, renal dysfunction will be excluded. Individuals with evidence of malignancy. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
1. Constipation or loose stool 2. Stools with foul odour 3. Pain in abdomen 4. Heaviness in abdomen 5. Abdominal distension 6. Anorexia 7. Lassitude 8. Burning sensation 9. Indigestion 10. Improperly formed stools Timepoint: Time point : 0 days 30th day 60th day	—

Secondary

Measure	Time frame
1. Bristol stool form scale 2. IBS-QOL 3. IBS- severity score Timepoint: Time point : 0 days 30th day 60th day	—

Countries

India

Contacts

Public ContactDr C B Dhanraj

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Uttarakhand India.

drcbdhanraj@gmail.com917396174582

Outcome results